Product Description
Mechanisms of Action: Epump
Novel Mechanism: Yes
Modality: Small Molecule
Route of Administration: Intravenous,Oral
FDA Designation: *
Approval Status: Not Approved
Approved Countries: Australia | Austria | Belgium | Bosnia | Brazil | Chile | China | Croatia | Cyprus | Egypt | France | Greece | Hong Kong | Hungary | India | Indonesia | Ireland | Israel | Lebanon | Malaysia | Malta | New Zealand | Norway | Pakistan | Poland | Russia | Serbia | South Africa | Spain | Sweden | Switzerland | Taiwan | Thailand | Turkey | Ukraine | United Arab Emirates | United Kingdom | United States | Uruguay | Venezuela | Vietnam
Approved Indications: None
Known Adverse Events: None
Company: Baxter Healthcare
Company Location: DEERFIELD IL 60015
Company CEO: José E. Almeida
Additional Commercial Interests: None
Clinical Description
Countries in Clinic: United States
Active Clinical Trial Count: 1
Recent & Upcoming Milestones
Highest Development Phases
Phase 2: Muscle Weakness
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|---|---|---|---|---|---|---|
| SeND Home | P2 |
Recruiting |
Muscle Weakness |
2025-06-30 |
2024-10-18 |
Recent News Events
Date |
Type |
Title |
|---|---|---|
|
06/11/2025 |
News Article |
Aptatek BioSciences, Inc. Announces Bridge Financing to Support Advancement of the PheCheck™ Aptamer-based In-home Monitoring Platform |
|
06/03/2025 |
News Article |
Myriad Genetics Announces Early Access to the FirstGene Multiple Prenatal Screen |
|
05/27/2025 |
News Article |
Thermostatic Mixing Valve Market to Reach USD 1,749.6 million By 2032, Growing At An 5 % CAGR - Credence Research |
|
04/28/2025 |
News Article |
Alto Neuroscience Presents New Data at the Society of Biological Psychiatry Annual Meeting Underscoring Precision Psychiatry Approach |